| 发明名称 |
METHOD FOR TREATING CANCER BASED ON MUTATION STATUS OF K-RAS |
| 摘要 |
The present invention provides methods and compositions for treating cancer by administering a) a composition comprising nanoparticles that comprise paclitaxel and an albumin and/or b) a therapeutic agent (e.g., gemcitabine) based upon K-ras mutation status. |
| 申请公布号 |
US2014199405(A1) |
申请公布日期 |
2014.07.17 |
| 申请号 |
US201313794712 |
申请日期 |
2013.03.11 |
| 申请人 |
Abraxis BioScience, LLC |
发明人 |
PIERCE Daniel;BRACHMANN Carrie |
| 分类号 |
A61K9/51;A61K31/7068;A61K31/337 |
主分类号 |
A61K9/51 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating cancer in an individual comprising administering to the individual an effective amount of a composition comprising nanoparticles comprising a taxane and an albumin, wherein the K-ras mutation status is used as a basis for selecting the individual for treatment. |
| 地址 |
Los Angeles CA US |
